American Marconi Wireless News

NYSE - LSE

RBGPF	0%	75.17	$
RYCEF	8.01%	17.86	$
BCE	-0.6%	21.49	$
BP	0.13%	44.59	$
GSK	2.35%	51.54	$
AZN	1.56%	189.39	$
BTI	-1.33%	60.09	$
RIO	3.08%	86.39	$
CMSC	2%	20.46	$
NGG	1.32%	84.26	$
BCC	3.21%	72.57	$
CMSD	1.61%	20.48	$
RELX	-0.37%	40.02	$
VOD	0.7%	15.69	$
JRI	2.51%	11.93	$

Featured

Spectrocell Strengthens Product Discovery and Customer Engagement with Bioz Badges

PALO ALTO, CA / ACCESS Newswire / November 10, 2026 / Bioz, Inc., a scientific intelligence platform that converts publication data into evidence for product evaluation, is helping Spectrocell turn research citations into meaningful customer engagement through Bioz Badges. By making published research accessible alongside product information, Spectrocell gives website visitors additional context to evaluate its products and understand their use in scientific applications.

InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 10

LONDON, UK / ACCESS Newswire / November 10, 2026 / The Company announces that on 09 November 2026 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 17 February 2026, as announced on 17 February 2026.

Last news

Court hearing as parent-killing Menendez brothers bid for freedom

Lyle and Erik Menendez are set to face a judge Monday as the campaign to free them from their life sentences for the shotgun murders of their parents gathers pace.

Closing arguments coming in US-Google antitrust trial on ad tech

Google and the US government will face off in a federal court on Monday, as each side delivers its closing arguments in a case revolving around the technology giant's alleged unfair domination of online advertising.

InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 25

Purchase of own shares

BioNxt Announces Enhanced Sublingual Product Development Pipeline with Innovative Solutions for Autoimmune Diseases and Longevity

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT) is pleased to announce the expansion of its next-generation product pipeline. This includes proprietary Sublingual (Thin-Film), Transdermal (Skin Patch), and Oral (Enteric-Coated Tablet) drug delivery systems targeting autoimmune diseases such as Multiple sclerosis ("MS"), Myasthenia gravis ("MG"), Lupus nephritis ("LN"), and Rheumatoid arthritis ("RA"), as well as an exciting initiative in the fast-growing longevity market. These advancements highlight BioNxt's commitment to developing innovative, patient-centric solutions to improve compliance, enhance drug bioavailability, and address critical unmet medical needs.

BloomZ to Manage Sound Production for the Upcoming Anime Adaptation "Dark Machine"

BloomZ Inc. (NASDAQ:BLMZ)("BloomZ" or the "Company"), a leading Japanese anime production, audio production, and voice actor management company, announced its involvement in the sound production for the upcoming anime adaptation project of Dark Machine, the eSports-inspired Web3 video game.

Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Alleged Spoofing/Stock Price Manipulation

Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) (the "Company") formerly named FSD Pharma Inc. (Nasdaq:HUGE)(CSE:HUGE) is pleased to follow up on recent events concerning the complaint filed by the Company in the United States courts, that alleges that CIBC World Markets, RBC Dominion Securities and others (the "Defendants") engaged in market manipulation in the share price of the Company. The Company, as well as its shareholders, have suffered financial and emotional losses resulting from this alleged manipulation. We are determined to right this wrong by the Defendants and reverse the Company losses and claim punitive damages to the extent determined by the courts. As a result, prominent legal teams have been assembled to pursue the recovery of all losses and damages impacting our Company. The law firms have agreed to be compensated without cost to the Company but solely on a contingency basis, meaning that the Company will not be billed for legal costs in this matter. The Company itself is seeking damages of more than US$700M we believe it has suffered. The shareholders can find updated information about the case on the Quantum vs Banks page of our website which will be updated periodically.

ISSA Show North America Elevates Global Cleaning, Facility Solutions and Public Health Standards at Annual Showcase

ISSA Show North America, the most comprehensive global event dedicated to cleaning and facility solutions, gathered more than 600 exhibiting brands to connect with distributors, building service contractors, facility service professionals and residential cleaning firms at the Mandalay Bay Convention Center, November 17-21.

CNS Pharmaceuticals Presents Update from Ongoing Potentially Pivotal Study of Berubicin Compared with Lomustine in Adult Patients with Recurrent GBM (WHO Grade IV) After Failure of Standard First Line Therapy

Poster presented at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)Primary analysis data in potentially pivotal GBM study with lead program, Berubicin, on track for the first half of 2025

Justera Health Revises Vesting Schedule of RSU Grant

Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ("Justera"or the"Company") announces that the Board of Directors has revised the vesting schedule of the Restricted Share Units ("RSUs") granted on November 8, 2024, to meet the CSE policy 6.1(4). The new vesting schedule is 50% of RSU will be vested four (4) months plus one (1) day from the issuance date, on March 9, 2025, and the remaining 50% of RSU will be vested six (6) months from the date of issuance, on May 8, 2025.

Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled

DehydraTECH-processed tirzepatide from Zepbound® is being tested in an oral dose format

Wellstack Partners With Hartford HealthCare to Advance Data Integration and Healthcare Analytics

Wellstack and Hartford HealthCare Partner to Drive Innovation in Data Integration and Patient-Centered Care

PV ModuleTech Conference Europe to Share Latest Trends in Solar Module Buying

Topics include solar module technologies, pricing, manufacturing costs and the impact of environmental, social and governance on module supplier selection.

Jaguar Health Presenting December 3rd at NobleCon20 and December 5th at the Emerging Growth Conference

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will present in person on December 3, 2024 at NobleCon20 - Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference, and present virtually on December 5, 2024 at the Emerging Growth Conference.

Moderna to Present at Upcoming Conferences in December 2024

Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:

Medicure Reports Financial Results For Quarter Ended September 30, 2024

Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter ended September 30, 2024.

Angara Named Luxury Brand of the Year at the 2024 Glossy Fashion and Luxury Awards

Recognized for Redefining Luxury with Affordable Custom Jewelry for All

Juva Life Inc. Updates Shareholders on Court-Appointed Receivership Proceedings

Juva Life Inc. (CSE:JUVA)(OTC PINK:JUVAF)(FRANKFURT:4VV) ("Juva" or the "Company"), a life science company with both pharmaceutical research and development and consumer-facing operations in cannabis production and distribution, announces that, as of November 7, 2024, the Superior Court of California, County of San Joaquin, appointed Kevin Singer of Receivership Specialists as the court-appointed receiver to oversee the Company's assets. This follows the Company's prior disclosure on November 5, 2024, that it anticipated this outcome as part of ongoing efforts to address its financial challenges.

Acreage Provides Update on Corporate Transactions

Acreage Holdings, Inc. ("Acreage" or the "Company") (CSE:ACRG.A.U, ACRG.B.U)(OTCQX:ACRHF, ACRDF), a vertically integrated, multi-state operator of cannabis cultivation and retailing facilities in the U.S., is pleased to announce that, further to its press releases of June 4 and June 5, 2024, Acreage anticipates that Canopy USA, LLC ("Canopy USA") will complete its acquisition of Acreage pursuant to the Acquisitions (as defined below) in mid-December, 2024.

US consumers to bargain hunt in annual 'Black Friday' spree

US shoppers are coming out in force this holiday season, but the festiveness is being tempered by inflationary pressures that have abated but not completely faded.

Tanzania Safaris Unveils New Luxury Adventure Packages for 2025

Experience the Wild in Unparalleled Comfort and Sustainability

Mass rape trial sparks demonstrations across France

Thousands demonstrated in major French cities Saturday against violence targeting women, as campaigners push for the country to learn from a mass rape trial that has shocked the public.

Pope to skip Notre Dame opening in Paris for Corsica visit

Pope Francis will visit the French Mediterranean island of Corsica in December, days after skipping the reopening of Paris's Notre Dame Cathedral which was ravaged by a fire in 2019, the Vatican said Saturday.

Balkans women stage ancient Greek play to condemn women's suffering in war

Maja Mitic is Serbian. Zana Hoxha is Kosovar. Their adaptation of an ancient Greek tragedy highlights not so much the devastation war inflicts on women but women's capacity to heal and resist.

Fears for Gaza hospitals as fuel and aid run low

The health ministry in Hamas-run Gaza said Friday that hospitals have only two days' fuel left before they must restrict services, after the UN warned aid delivery to the war-devastated territory is being crippled.

Sean Combs bail ruling to come next week: US media

Music mogul Sean "Diddy" Combs, who has been charged with sex trafficking and racketeering, appeared in court Friday again seeking bail, but a judge deferred the decision to next week, US media reported.

Woman wins civil damages claim against MMA star Conor McGregor over rape accusation

A woman on Friday won a civil court damages claim against mixed martial arts fighter Conor McGregor over her allegation that he raped her in a Dublin hotel in 2018.

Kenya knew about arrest of opposition figure: Uganda govt

The arrest of a Ugandan opposition figure in Kenya was carried out with Nairobi's knowledge, a Ugandan government spokesperson told AFP Friday.

Investors seek 750 mn euros in damages over Wirecard collapse

A lawsuit by Wirecard investors claiming 750 million euros ($780 million) in compensation over the German payment company's collapse in a 2020 fraud scandal had its first hearing on Friday.

Hong Kong seniors celebrate life with mass marriage vow renewal

Rowdy cheers spilled from a Hong Kong banquet hall hosting a mass wedding party, as one of the 20 elderly couples renewing their vows coquettishly shared a strawberry marshmallow mouth-to-mouth.

InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 22

The Company announces that on 21 November 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.

Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced it ranked 380th on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America, now in its 30th year.

Hemogenyx Pharmaceuticals PLC Announces Notice of Extraordinary General Meeting

Hemogenyx Pharmaceuticals plc("Hemogenyx Pharmaceuticals" or the "Company")Notice of Extraordinary General MeetingProposed Capital Reorganisation and New Articles of Association

American Marconi Wireless News - Boulevard (English)